Replies to post #35164 on RespireRx Pharmaceuticals Inc (fka RSPI)

[bladerunner1717]

gfp,

I don't see how Samyang is going to put up with a huge dilution or with another equity partner. That makes no sense to me at all. CORX may just as well sell the company. It's either a partnership or nothing, if they don't sell. I don't see more dilution helping them much at this point, even for some needed cash (unless it's more from Samyang).


Bladerunner

[meixatech]

"Having to hire an SA consultant to help with the analysis would make sense."

No, the SA expert should have assisted BEFORE the trial. It would make no sense to hire one after it. Cortex had to be sure of the reliability of the data for analysis – a SA expert would (hopefully) do that.

“To make valid inferences about a population, we must be reasonably certain that the sample is representative of the population” – Byrkit, D.R. 1987

The set up of the trial should have already indicated the statistical procedures for the analysis. At the end of the trial, it is a good statistician that is important, not a SA expert. It takes a statistician to recognize that the proposed statistical procedures are not powerful enough or are wrong for the data set and apply procedures that will produce a reliable conclusion.

[jerrydylan]

My gleening from a discussion is simple, though I don't understand why. It is being analyzed now.